Eisai Enters Biologics Arena With $325 Million Morphotek Acquisition
This article was originally published in The Pink Sheet Daily
Executive Summary
Japanese firm plans to grow U.S. sales to $4 billion via expanded sales force of 1,500 by 2011, Eisai tells “The Pink Sheet” DAILY.